Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy

The efficacy of repeated treatment with B-cell depletion therapy in systemic lupus erythematosus: an evaluation

(2011) T. Turner-Stokes et al.   RHEUMATOLOGY

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

High incidence ofPneumocystis jiroveciipneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone

(2010) Sarah Kamel et al.   LEUKEMIA & LYMPHOMA

Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus

(2010) F. Catapano et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis

(2010) Boris Hugle et al.   ARTHRITIS CARE & RESEARCH

Depletion of functionally active CD20+ T cells by rituximab treatment

(2009) Esther Wilk et al.   ARTHRITIS AND RHEUMATISM

Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis

(2008) L. L. Teichmann et al.   RHEUMATOLOGY

Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus

(2008) Ratchaya Lertnawapan et al.   RHEUMATOLOGY INTERNATIONAL

Pneumocystis jiroveciipneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient

(2008) D. Kumar et al.   Transplant Infectious Disease